Instadose Pharma Corp.
INSD
$0.00
$0.000.00%
OTC PK
| 02/28/2022 | 02/28/2021 | ||||
|---|---|---|---|---|---|
| Net Income | -906.30K | -10.43M | |||
| Total Depreciation and Amortization | 379.60K | 378.40K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -- | 9.57M | |||
| Change in Net Operating Assets | 652.90K | 55.10K | |||
| Cash from Operations | 126.20K | -420.30K | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 3.80K | -186.60K | |||
| Cash from Investing | 3.80K | -186.60K | |||
| Total Debt Issued | 28.80K | 797.40K | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -206.10K | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -139.50K | 625.40K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -9.50K | 18.50K | |||